In search of partners: linking extracellular proteases to substrates

[1]  Christopher M Overall,et al.  Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.

[2]  C. Overall,et al.  Proteomic discovery of protease substrates. , 2007, Current opinion in chemical biology.

[3]  Benjamin F. Cravatt,et al.  Genomics and proteomics: From genes to function: advances in applications of chemical and systems biology , 2007 .

[4]  K. Horiuchi,et al.  Correction for Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx , 2006, Molecular biology of the cell.

[5]  C. Overall,et al.  Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry. , 2007, Current pharmaceutical design.

[6]  Y. Kadono,et al.  Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand* , 2006, Journal of Biological Chemistry.

[7]  S. Umland,et al.  ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23 , 2006, Nature Immunology.

[8]  P. Saftig,et al.  Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.

[9]  D. Greenspan,et al.  BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein , 2006, The Journal of cell biology.

[10]  Bonnie Peng,et al.  The role of prohormone convertase‐2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study , 2006, Journal of neurochemistry.

[11]  B. Turk.  Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[12]  C. Blobel,et al.  ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression , 2006, Oncogene.

[13]  C. Haass,et al.  A Basolateral Sorting Signal Directs ADAM10 to Adherens Junctions and Is Required for Its Function in Cell Migration* , 2006, Journal of Biological Chemistry.

[14]  Bonnie F. Sloane,et al.  Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. , 2006, Cancer research.

[15]  J. Baselga,et al.  Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis , 2006, Molecular and Cellular Biology.

[16]  W. Kisiel,et al.  ADAMTS1 Interacts with, Cleaves, and Modifies the Extracellular Location of the Matrix Inhibitor Tissue Factor Pathway Inhibitor-2* , 2006, Journal of Biological Chemistry.

[17]  D. Hanahan,et al.  Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. , 2006, Genes & development.

[18]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[19]  S. Umland,et al.  ADAM 10 is a principal ‘ sheddase ’ of the low-affinity immunoglobulin E receptor CD 23 , 2006 .

[20]  R. Beynon,et al.  Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides , 2005, Nature Methods.

[21]  Liang Li,et al.  Differential dimethyl labeling of N-termini of peptides after guanidination for proteome analysis. , 2005, Journal of proteome research.

[22]  K. Gevaert,et al.  Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis , 2005, Nature Methods.

[23]  Z. Werb,et al.  Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin , 2005, Development.

[24]  M. Blank,et al.  Aptamers as tools for target validation. , 2005, Current opinion in chemical biology.

[25]  Tomoyuki Shirai,et al.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. , 2005, Cancer cell.

[26]  L. Coussens,et al.  De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. , 2005, Cancer cell.

[27]  K. Taira,et al.  Gene discovery by ribozyme and siRNA libraries , 2005, Nature Reviews Molecular Cell Biology.

[28]  A. Fourie,et al.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro , 2005, Nature.

[29]  H. Ma,et al.  Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.

[30]  M. Åbrink,et al.  A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.

[31]  James C. Whisstock,et al.  Pops: a Computational Tool for Modeling and Predicting Protease Specificity , 2004, J. Bioinform. Comput. Biol..

[32]  M. Ahram,et al.  A proteomic approach to characterize protein shedding , 2005, Proteomics.

[33]  W. Forssmann,et al.  Exploiting natural peptide diversity: novel research tools and drug leads. , 2004, Current opinion in biotechnology.

[34]  Sung Goo Park,et al.  Identification of caspase‐3 degradome by two‐dimensional gel electrophoresis and matrix‐assisted laser desorption/ionization‐time of flight analysis , 2004, Proteomics.

[35]  C. Overall.  Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. , 2004, The Biochemical journal.

[36]  S. M. Park,et al.  A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. , 2004, Biochimica et biophysica acta.

[37]  L. Giudice,et al.  The Lin12-Notch Repeats of Pregnancy-associated Plasma Protein-A Bind Calcium and Determine Its Proteolytic Specificity* , 2004, Journal of Biological Chemistry.

[38]  T. Ley,et al.  A proteomic approach for the discovery of protease substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Blobel,et al.  Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor α (TNFα) Shedding and of the Function of the TNFα Ectodomain in Ensuring Selective Stimulated Shedding by the TNFα Convertase (TACE/ADAM17)* , 2004, Journal of Biological Chemistry.

[40]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[41]  M. Åbrink,et al.  Cooperation between Mast Cell Carboxypeptidase A and the Chymase Mouse Mast Cell Protease 4 in the Formation and Degradation of Angiotensin II* , 2004, Journal of Biological Chemistry.

[42]  M. Milla,et al.  Inhibition of the Tumor Necrosis Factor-α-converting Enzyme by Its Pro Domain* , 2004, Journal of Biological Chemistry.

[43]  Nasreen S Jessani,et al.  Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. de Strooper,et al.  Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation , 2004, The Journal of cell biology.

[45]  David C. Lee,et al.  Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. , 2004, The Journal of biological chemistry.

[46]  S. Howell,et al.  Proteomic Analysis of Cleavage Events Reveals a Dynamic Two-step Mechanism for Proteolysis of a Key Parasite Adhesive Complex* , 2004, Molecular & Cellular Proteomics.

[47]  M. Stack,et al.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Ortiz de Montellano,et al.  Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  V. Quaranta,et al.  Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[50]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[51]  L. Cantley,et al.  Using peptide libraries to identify optimal cleavage motifs for proteolytic enzymes. , 2004, Methods.

[52]  Jun Zou,et al.  Catalytic Activity of Human ADAM33* , 2004, Journal of Biological Chemistry.

[53]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[54]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[55]  X. Puente,et al.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.

[56]  P. Roughley,et al.  Production of antibodies against degradative neoepitopes in aggrecan. , 2004, Methods in molecular medicine.

[57]  M. Milla,et al.  Inhibition of the TNF a Converting Enzyme ( TACE ) by its Pro Domain , 2004 .

[58]  Erdogan Gulari,et al.  High density peptide microarrays. In situ synthesis and applications , 2004, Molecular Diversity.

[59]  James C. Whisstock,et al.  PoPS: a computational tool for modeling and predicting protease specificity , 2004, Proceedings. 2004 IEEE Computational Systems Bioinformatics Conference, 2004. CSB 2004..

[60]  Y. Kaneda,et al.  Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities , 2003, The Journal of cell biology.

[61]  C. Overall,et al.  HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration , 2003, Nature Neuroscience.

[62]  R. Williamson,et al.  Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. , 2003, Biochemical Society symposium.

[63]  K. Horiuchi,et al.  Potential Role for ADAM15 in Pathological Neovascularization in Mice , 2003, Molecular and Cellular Biology.

[64]  M. Wolfe,et al.  Intramembrane proteolysis by presenilin and presenilin-like proteases , 2003, Journal of Cell Science.

[65]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[66]  P. Griffin,et al.  The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides , 2003, Journal of Biological Chemistry.

[67]  F. Gomis-Rüth,et al.  Structural aspects of the metzincin clan of metalloendopeptidases , 2003, Molecular biotechnology.

[68]  David C. Lee,et al.  Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.

[69]  Stefan Hart,et al.  TACE cleavage of proamphiregulin regulates GPCR‐induced proliferation and motility of cancer cells , 2003, The EMBO journal.

[70]  C. Blobel,et al.  Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs). , 2003, Current topics in developmental biology.

[71]  C. Craik,et al.  Scanning the prime-site substrate specificity of proteolytic enzymes: a novel assay based on ligand-enhanced lanthanide ion fluorescence. , 2002, Bioorganic & medicinal chemistry letters.

[72]  William C. Parks,et al.  Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.

[73]  Dustin J Maly,et al.  Peptide microarrays for the determination of protease substrate specificity. , 2002, Journal of the American Chemical Society.

[74]  B. de Strooper,et al.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. , 2002, Human molecular genetics.

[75]  Irwin D Kuntz,et al.  Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. , 2002, Chemistry & biology.

[76]  C. Overall.  Molecular determinants of metalloproteinase substrate specificity , 2002, Molecular biotechnology.

[77]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[78]  C. López-Otín,et al.  Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.

[79]  N. Hooper,et al.  Structure−Activity Relationship of Hydroxamate-Based Inhibitors on the Secretases that Cleave the Amyloid Precursor Protein, Angiotensin Converting Enzyme, CD23, and Pro-Tumor Necrosis Factor-α† , 2002 .

[80]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[81]  C. Overall,et al.  Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.

[82]  R. Paxton,et al.  A Proteomic Approach for the Identification of Cell-surface Proteins Shed by Metalloproteases* , 2002, Molecular & Cellular Proteomics.

[83]  M. Schrader,et al.  Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. , 2012, Combinatorial chemistry & high throughput screening.

[84]  P. Wei,et al.  Inhibitory antibodies against endopeptidase activity of human adamalysin 19. , 2001, Biochemical and biophysical research communications.

[85]  J. Cyster,et al.  Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. , 2001, Immunity.

[86]  L. Cantley,et al.  Determination of protease cleavage site motifs using mixture-based oriented peptide libraries , 2001, Nature Biotechnology.

[87]  N. Hooper,et al.  A Point Mutation in the Juxtamembrane Stalk of Human Angiotensin I-converting Enzyme Invokes the Action of a Distinct Secretase* , 2001, The Journal of Biological Chemistry.

[88]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[89]  L. Lum,et al.  Biochemical and Pharmacological Criteria Define Two Shedding Activities for TRANCE/OPGL That Are Distinct from the Tumor Necrosis Factor α Convertase* , 2001, The Journal of Biological Chemistry.

[90]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[91]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[92]  T. Burn,et al.  The Thrombospondin Motif of Aggrecanase-1 (ADAMTS-4) Is Critical for Aggrecan Substrate Recognition and Cleavage* , 2000, The Journal of Biological Chemistry.

[93]  M. Page,et al.  Rapid identification of substrates for novel proteases using a combinatorial peptide library. , 2000, Journal of combinatorial chemistry.

[94]  B. Fingleton,et al.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.

[95]  R. Derynck,et al.  Ectodomain shedding of TGF‐α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades , 1999, The EMBO journal.

[96]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[97]  M. Lambert,et al.  Specific Sequence Elements Are Required for the Expression of Functional Tumor Necrosis Factor-α-converting Enzyme (TACE)* , 1999, The Journal of Biological Chemistry.

[98]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[99]  M. Overgaard,et al.  Regulation of Human ADAM 12 Protease by the Prodomain , 1999, The Journal of Biological Chemistry.

[100]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[101]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[102]  E. Kojro,et al.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[103]  G. Weskamp,et al.  Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity* , 1999, The Journal of Biological Chemistry.

[104]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[105]  David C. Lee,et al.  An essential role for ectodomain shedding in mammalian development. , 1998, Science.

[106]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[107]  Joseph D. Buxbaum,et al.  Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.

[108]  E. Engvall,et al.  Human ADAM 12 (Meltrin α) Is an Active Metalloprotease* , 1998, The Journal of Biological Chemistry.

[109]  M. Metzstein,et al.  SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. , 1997, Development.

[110]  M. T. Brewer,et al.  Identification and Characterization of a Pro-tumor Necrosis Factor-α-processing Enzyme from the ADAM Family of Zinc Metalloproteases* , 1997, The Journal of Biological Chemistry.

[111]  G. Rubin,et al.  Kuzbanian Controls Proteolytic Processing of Notch and Mediates Lateral Inhibition during Drosophila and Vertebrate Neurogenesis , 1997, Cell.

[112]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[113]  C. Rorabeck,et al.  Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. , 1997, The Journal of clinical investigation.

[114]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[115]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[116]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[117]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[118]  M. Navre,et al.  Rapid Identification of Highly Active and Selective Substrates for Stromelysin and Matrilysin Using Bacteriophage Peptide Display Libraries (*) , 1995, The Journal of Biological Chemistry.

[119]  R. Huber,et al.  X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. , 1995, European journal of biochemistry.

[120]  R. Huber,et al.  X‐ray Structures of Human Neutrophil Collagenase Complexed with Peptide Hydroxamate and Peptide Thiol Inhibitors , 1995 .

[121]  J. Wells,et al.  Substrate phage: selection of protease substrates by monovalent phage display. , 1993, Science.

[122]  R. Anderegg,et al.  Rapid optimization of enzyme substrates using defined substrate mixtures. , 1992, The Journal of biological chemistry.

[123]  G. Fields,et al.  A model for interstitial collagen catabolism by mammalian collagenases. , 1991, Journal of theoretical biology.

[124]  D. Henner,et al.  Engineering human prolactin to bind to the human growth hormone receptor. , 1990, Science.

[125]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[126]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[127]  R. Macfarlane.  An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[128]  E. Davie,et al.  Identification of a peptide released during autocatalytic activation of trypsinogen. , 1955, The Journal of biological chemistry.